[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Intrauterine Contraceptive Devices-United States Market Status and Trend Report 2013-2023

February 2018 | 157 pages | ID: ID2A485BDC6MEN
MIReports Co., Limited

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Summary

Intrauterine Contraceptive Devices-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Intrauterine Contraceptive Devices industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Whole United States and Regional Market Size of Intrauterine Contraceptive Devices 2013-2017, and development forecast 2018-2023
Main market players of Intrauterine Contraceptive Devices in United States, with company and product introduction, position in the Intrauterine Contraceptive Devices market
Market status and development trend of Intrauterine Contraceptive Devices by types and applications
Cost and profit status of Intrauterine Contraceptive Devices, and marketing status
Market growth drivers and challenges

The report segments the United States Intrauterine Contraceptive Devices market as:

United States Intrauterine Contraceptive Devices Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):

New England
The Middle Atlantic
The Midwest
The West
The South
Southwest

United States Intrauterine Contraceptive Devices Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):

Hormonal IUCD
Copper IUCD

United States Intrauterine Contraceptive Devices Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)

Hospitals
Gynecological Clinics
Other

United States Intrauterine Contraceptive Devices Market: Players Segment Analysis (Company and Product introduction, Intrauterine Contraceptive Devices Sales Volume, Revenue, Price and Gross Margin):

Teva Pharmaceutical Industries
Medicines360
Trimedic Supply Network Ltd.
Bayer Healthcare Ag (Subsidiary of Bayer Ag)
Actavis PLC
Medisafe Distribution Inc.
Pace Pharmaceuticals

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF INTRAUTERINE CONTRACEPTIVE DEVICES

1.1 Definition of Intrauterine Contraceptive Devices in This Report
1.2 Commercial Types of Intrauterine Contraceptive Devices
  1.2.1 Hormonal IUCD
  1.2.2 Copper IUCD
1.3 Downstream Application of Intrauterine Contraceptive Devices
  1.3.1 Hospitals
  1.3.2 Gynecological Clinics
  1.3.3 Other
1.4 Development History of Intrauterine Contraceptive Devices
1.5 Market Status and Trend of Intrauterine Contraceptive Devices 2013-2023
  1.5.1 United States Intrauterine Contraceptive Devices Market Status and Trend 2013-2023
  1.5.2 Regional Intrauterine Contraceptive Devices Market Status and Trend 2013-2023

CHAPTER 2 UNITED STATES MARKET STATUS AND FORECAST BY REGIONS

2.1 Market Status of Intrauterine Contraceptive Devices in United States 2013-2017
2.2 Consumption Market of Intrauterine Contraceptive Devices in United States by Regions
  2.2.1 Consumption Volume of Intrauterine Contraceptive Devices in United States by Regions
  2.2.2 Revenue of Intrauterine Contraceptive Devices in United States by Regions
2.3 Market Analysis of Intrauterine Contraceptive Devices in United States by Regions
  2.3.1 Market Analysis of Intrauterine Contraceptive Devices in New England 2013-2017
  2.3.2 Market Analysis of Intrauterine Contraceptive Devices in The Middle Atlantic 2013-2017
  2.3.3 Market Analysis of Intrauterine Contraceptive Devices in The Midwest 2013-2017
  2.3.4 Market Analysis of Intrauterine Contraceptive Devices in The West 2013-2017
  2.3.5 Market Analysis of Intrauterine Contraceptive Devices in The South 2013-2017
  2.3.6 Market Analysis of Intrauterine Contraceptive Devices in Southwest 2013-2017
2.4 Market Development Forecast of Intrauterine Contraceptive Devices in United States 2018-2023
  2.4.1 Market Development Forecast of Intrauterine Contraceptive Devices in United States 2018-2023
  2.4.2 Market Development Forecast of Intrauterine Contraceptive Devices by Regions 2018-2023

CHAPTER 3 UNITED STATES MARKET STATUS AND FORECAST BY TYPES

3.1 Whole United States Market Status by Types
  3.1.1 Consumption Volume of Intrauterine Contraceptive Devices in United States by Types
  3.1.2 Revenue of Intrauterine Contraceptive Devices in United States by Types
3.2 United States Market Status by Types in Major Countries
  3.2.1 Market Status by Types in New England
  3.2.2 Market Status by Types in The Middle Atlantic
  3.2.3 Market Status by Types in The Midwest
  3.2.4 Market Status by Types in The West
  3.2.5 Market Status by Types in The South
  3.2.6 Market Status by Types in Southwest
3.3 Market Forecast of Intrauterine Contraceptive Devices in United States by Types

CHAPTER 4 UNITED STATES MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY

4.1 Demand Volume of Intrauterine Contraceptive Devices in United States by Downstream Industry
4.2 Demand Volume of Intrauterine Contraceptive Devices by Downstream Industry in Major Countries
  4.2.1 Demand Volume of Intrauterine Contraceptive Devices by Downstream Industry in New England
  4.2.2 Demand Volume of Intrauterine Contraceptive Devices by Downstream Industry in The Middle Atlantic
  4.2.3 Demand Volume of Intrauterine Contraceptive Devices by Downstream Industry in The Midwest
  4.2.4 Demand Volume of Intrauterine Contraceptive Devices by Downstream Industry in The West
  4.2.5 Demand Volume of Intrauterine Contraceptive Devices by Downstream Industry in The South
  4.2.6 Demand Volume of Intrauterine Contraceptive Devices by Downstream Industry in Southwest
4.3 Market Forecast of Intrauterine Contraceptive Devices in United States by Downstream Industry

CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF INTRAUTERINE CONTRACEPTIVE DEVICES

5.1 United States Economy Situation and Trend Overview
5.2 Intrauterine Contraceptive Devices Downstream Industry Situation and Trend Overview

CHAPTER 6 INTRAUTERINE CONTRACEPTIVE DEVICES MARKET COMPETITION STATUS BY MAJOR PLAYERS IN UNITED STATES

6.1 Sales Volume of Intrauterine Contraceptive Devices in United States by Major Players
6.2 Revenue of Intrauterine Contraceptive Devices in United States by Major Players
6.3 Basic Information of Intrauterine Contraceptive Devices by Major Players
  6.3.1 Headquarters Location and Established Time of Intrauterine Contraceptive Devices Major Players
  6.3.2 Employees and Revenue Level of Intrauterine Contraceptive Devices Major Players
6.4 Market Competition News and Trend
  6.4.1 Merger, Consolidation or Acquisition News
  6.4.2 Investment or Disinvestment News
  6.4.3 New Product Development and Launch

CHAPTER 7 INTRAUTERINE CONTRACEPTIVE DEVICES MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA

7.1 Teva Pharmaceutical Industries
  7.1.1 Company profile
  7.1.2 Representative Intrauterine Contraceptive Devices Product
  7.1.3 Intrauterine Contraceptive Devices Sales, Revenue, Price and Gross Margin of Teva Pharmaceutical Industries
7.2 Medicines360
  7.2.1 Company profile
  7.2.2 Representative Intrauterine Contraceptive Devices Product
  7.2.3 Intrauterine Contraceptive Devices Sales, Revenue, Price and Gross Margin of Medicines360
7.3 Trimedic Supply Network Ltd.
  7.3.1 Company profile
  7.3.2 Representative Intrauterine Contraceptive Devices Product
  7.3.3 Intrauterine Contraceptive Devices Sales, Revenue, Price and Gross Margin of Trimedic Supply Network Ltd.
7.4 Bayer Healthcare Ag (Subsidiary of Bayer Ag)
  7.4.1 Company profile
  7.4.2 Representative Intrauterine Contraceptive Devices Product
  7.4.3 Intrauterine Contraceptive Devices Sales, Revenue, Price and Gross Margin of Bayer Healthcare Ag (Subsidiary of Bayer Ag)
7.5 Actavis PLC
  7.5.1 Company profile
  7.5.2 Representative Intrauterine Contraceptive Devices Product
  7.5.3 Intrauterine Contraceptive Devices Sales, Revenue, Price and Gross Margin of Actavis PLC
7.6 Medisafe Distribution Inc.
  7.6.1 Company profile
  7.6.2 Representative Intrauterine Contraceptive Devices Product
  7.6.3 Intrauterine Contraceptive Devices Sales, Revenue, Price and Gross Margin of Medisafe Distribution Inc.
7.7 Pace Pharmaceuticals
  7.7.1 Company profile
  7.7.2 Representative Intrauterine Contraceptive Devices Product
  7.7.3 Intrauterine Contraceptive Devices Sales, Revenue, Price and Gross Margin of Pace Pharmaceuticals

CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF INTRAUTERINE CONTRACEPTIVE DEVICES

8.1 Industry Chain of Intrauterine Contraceptive Devices
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis

CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF INTRAUTERINE CONTRACEPTIVE DEVICES

9.1 Cost Structure Analysis of Intrauterine Contraceptive Devices
9.2 Raw Materials Cost Analysis of Intrauterine Contraceptive Devices
9.3 Labor Cost Analysis of Intrauterine Contraceptive Devices
9.4 Manufacturing Expenses Analysis of Intrauterine Contraceptive Devices

CHAPTER 10 MARKETING STATUS ANALYSIS OF INTRAUTERINE CONTRACEPTIVE DEVICES

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 REPORT CONCLUSION

CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE

12.1 Methodology/Research Approach
  12.1.1 Research Programs/Design
  12.1.2 Market Size Estimation
  12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
  12.2.1 Secondary Sources
  12.2.2 Primary Sources
12.3 Reference


More Publications